Clinical Trials List
2026-03-01 - 2043-12-31
Phase III
Recruiting5
-
Trial Applicant
Merck Sharp & Dohme (I.A.) LLC
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Chin-Wei Kuo 無
- Seu-Chun Yang 無
- Chun-Hui Lee 無
- 張超群 無
- 黃維立 無
- Yi-Ting Yen 無
- 林建佑 無
- Chian-Wei Chen 無
- Shang-Yin Wu 無
- Po-Lan Su 無
- 蔡政軒 無
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
12 participants
-
Global
400 participants
